An update on drugs with therapeutic potential for SARS-CoV-2 (COVID-19) treatment
Sylwester Drożdżal, Jakub Rosik, Kacper Lechowicz, Filip Machaj, Bartosz Szostak, Jarosław Przybyciński, Shahrokh Lorzadeh, Katarzyna Kotfis, Saeid Ghavami, Marek Łoś
Topics & Concepts
MedicineHydroxychloroquinePandemicLopinavirCoronavirus disease 2019 (COVID-19)RibavirinIntensive care medicineRitonavirInterim analysisClinical endpointRandomized controlled trialInterimDiseaseInternal medicineViral loadVirologyVirusInfectious disease (medical specialty)Hepatitis C virusHistoryArchaeologyAntiretroviral therapyCOVID-19 Clinical Research StudiesSARS-CoV-2 and COVID-19 ResearchLong-Term Effects of COVID-19